QY Research has published a new report named Global Crude Heparin Market Research Report 2020. the global Crude Heparin size is estimated to be 3585.30 million USD in 2020 from 2881.82 million USD in 2019, with a change 24.41% between 2019 and 2020. The global crude heparin market size is expected to grow at 8.79% or more annually for the next six years.
Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product.
Global Crude Heparin Market- Key Players
Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals are some of the key players, functioning in the global crude heparin market. Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend are global leading players in the market.
COVID-19 Stimulates the Crude Heparin Market
COVID-19 virus outbroke in the early 2020 and then spread fast globally. In the past few months, many countries, such as USA, India, Brazil have suffered COVID-19 virus outbreak consecutively. To date no specific antiviral drug have been approved for COVID-19, so the treatment of the disease is mainly focused on symptomatic treatment and supportive care. Moreover, there are no treatments of proven efficacy to reduce the progression of the disease from mild/moderate to severe/critical. An activation of the coagulation cascade leading to severe hypercoagulability has been detected in these patients, therefore early anticoagulation may reduce coagulopathy, microthrombus formation, and the risk of organ damages. The role of heparin in COVID-19 is supported by a lot of studies describing its pleiotropic activity but it must be proven in clinical trials. Several protocols have been designed to assess the risk-benefit profile of heparin (low-molecular-weight or unfractionated heparin) in hospitalized subjects. Although prophylactic doses may be adequate in most patients, it is important to wait the results of clinical trials in order to define the appropriate effective dose able to improve disease outcome.
Focus on the heparin has stimulated the crude heparin market. QYResearch estimates the global market size can reach 3.56 billion USD in 2020 due to the COVID-19, with the growth of 24.41%, compared with 2019.
Global Crude Heparin Market: Segmental Analysis
On the basis of product type, the global crude heparin market is segmented into pig intestine mucosa heparin, bovine heparin, etc. Presently, nearly all of the crude heparin in the market is derived from pit pig intestine mucosa. Other sources are rarely used.
Global Crude Heparin Market: Regional Analysis
In the report, North America, Europe, Asia-Pacific, South America, Middle East & Africa are analyzed. China is the largest producer of crude heparin. In 2019, about 56% crude heparin are originated from the country. Europe and USA can also provide a certain amount of crude heparin. As for some regions, they mainly depend on import to meet their own demand.
Read More Information: https://www.qyresearch.com/index/detail/1420349/global-crude-heparin-market
QY Research is the most reliable and trustworthy source of market research, established in the year 2007. We provide the best and the most syndicated research reports which focuses on custom research but not limited to management consulting, IPO consulting, industry chain research, and data base and seminar services. We provide market research reports on Chemical and material, machinery and equipment, electronics and semiconductor, consumer goods, energy and power, healthcare etc...
Rahul Singh - Digital Marketing Director
Contact: +91 7028 920 828
Sales Contact US:
USA Registered Office: QY Research, INC.
17890 Castleton, Suite 369,
City of industry, CA - 91748
Emails – firstname.lastname@example.org
Web – www.qyresearch.com